Literature DB >> 12874685

Comparison of objective outcomes following laparoscopic Nissen fundoplication versus laparoscopic gastric bypass in the morbidly obese with heartburn.

E J Patterson1, D G Davis, Y Khajanchee, L L Swanström.   

Abstract

BACKGROUND: Heartburn and gastroesophageal reflux disease (GERD) affects approximately 25-50% of morbidly obese patients. Although objective physiologic testing has been reported extensively in patients following Nissen fundoplication, there are no previous reports of such testing in morbidly obese patients. A life-saving surgical alternative for the morbidly obese patient is gastric bypass surgery, which usually improves heartburn symptoms in addition to many serious health conditions such as diabetes, hypertension, and sleep apnea. We hypothesized that, in morbidly obese patients, gastric bypass surgery would be as effective as Nissen fundoplication in reducing both heartburn symptoms and esophageal acid exposure, as reflected by the DeMeester score.
METHODS: Between 1995 and 2000, all patients undergoing laparoscopic Nissen fundoplication (LN) and laparoscopic gastric bypass (LGB) in our practice underwent preoperative and postoperative esophageal physiologic testing. Patients were included in this study that were morbidly obese and had significant heartburn symptoms or objective evidence of acid reflux, and had repeat esophageal physiologic testing after either LN or LGB. Data were obtained through retrospective review of prospectively collected data.
RESULTS: Twelve patients met the inclusion criteria: six patients who had LN and six who had LGB. The mean body mass index (BMI) was 55 kg/m2 in the LGB group and 39.8 in the LN group. After surgery, the mean DeMeester score decreased from 64.3 to 2.8 in the LN group ( p = 0.01) and from 34.7 to 5.7 in the LGB group ( p = 0.1). Both groups' mean postoperative DeMeester scores were normal after surgery, and there was no significant difference between the two groups ( p = 0.3). Both groups experienced a significant improvement in heartburn symptoms postoperatively. The mean preoperative symptom score improved from 3.5 to 0.5 in the LN group ( p = 0.01) and from 2.2 to 0.2 in the LGB group ( p = 0.003). There was no difference in the mean postoperative symptom scores between the groups ( p = 0.35). After surgery, mean LES resting pressures increased from 12.9 to 35.5 ( p = 0.003) in the LN group and from 23.6 to 29.7 ( p = 0.45) in the LGB group. There were no complications in either group.
CONCLUSION: Results of this study show that laparoscopic gastric bypass and laparoscopic Nissen fundoplication are both effective in treating heartburn symptoms and objective acid reflux in morbidly obese patients. The health benefits of weight loss after laparoscopic gastric bypass should make this operation the procedure of choice in the morbidly obese patient with heartburn.

Entities:  

Mesh:

Year:  2003        PMID: 12874685     DOI: 10.1007/s00464-002-8955-y

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  15 in total

1.  Gastroesophageal reflux after intact vertical banded gastroplasty: correction by conversion to Roux-en-Y gastric bypass.

Authors:  B M Balsiger; M M Murr; J Mai; M G Sarr
Journal:  J Gastrointest Surg       Date:  2000 May-Jun       Impact factor: 3.452

2.  A comparison study of laparoscopic versus open gastric bypass for morbid obesity.

Authors:  N T Nguyen; H S Ho; L S Palmer; B M Wolfe
Journal:  J Am Coll Surg       Date:  2000-08       Impact factor: 6.113

Review 3.  Gastrointestinal surgery for severe obesity. Proceedings of a National Institutes of Health Consensus Development Conference. March 25-27, 1991, Bethesda, MD.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

4.  Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity.

Authors:  P R Schauer; S Ikramuddin; W Gourash; R Ramanathan; J Luketich
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

5.  Obesity correlates with gastroesophageal reflux.

Authors:  B L Fisher; A Pennathur; J L Mutnick; A G Little
Journal:  Dig Dis Sci       Date:  1999-11       Impact factor: 3.199

6.  Elevated body mass disrupts the barrier to gastroesophageal reflux; discussion 1018-9.

Authors:  S A Wajed; C G Streets; C G Bremner; T R DeMeester
Journal:  Arch Surg       Date:  2001-09

7.  Symptomatic and clinical improvement in morbidly obese patients with gastroesophageal reflux disease following Roux-en-Y gastric bypass.

Authors:  S C Smith; C B Edwards; G N Goodman
Journal:  Obes Surg       Date:  1997-12       Impact factor: 4.129

8.  Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3-60 month follow-up.

Authors:  A C Wittgrove; G W Clark
Journal:  Obes Surg       Date:  2000-06       Impact factor: 4.129

9.  Does massive obesity promote abnormal gastroesophageal reflux?

Authors:  L Lundell; M Ruth; N Sandberg; M Bove-Nielsen
Journal:  Dig Dis Sci       Date:  1995-08       Impact factor: 3.199

10.  Conversion of failed or complicated vertical banded gastroplasty to gastric bypass in morbid obesity.

Authors:  H J Sugerman; J M Kellum; E J DeMaria; H D Reines
Journal:  Am J Surg       Date:  1996-02       Impact factor: 2.565

View more
  42 in total

Review 1.  Guidelines for surgical treatment of gastroesophageal reflux disease.

Authors:  Dimitrios Stefanidis; William W Hope; Geoffrey P Kohn; Patrick R Reardon; William S Richardson; Robert D Fanelli
Journal:  Surg Endosc       Date:  2010-08-20       Impact factor: 4.584

2.  Advances in GERD: Current Developments in the Management of Acid-Related GI Disorders.

Authors: 
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-02

3.  Complications and Surveillance After Bariatric Surgery.

Authors:  Seth J Concors; Brett L Ecker; Richard Maduka; Alyssa Furukawa; Steven E Raper; Daniel D Dempsey; Noel N Williams; Kristoffel R Dumon
Journal:  Curr Treat Options Neurol       Date:  2016-01       Impact factor: 3.598

4.  The rise and fall of antireflux surgery in the United States.

Authors:  Jonathan F Finks; Yongliang Wei; John D Birkmeyer
Journal:  Surg Endosc       Date:  2006-09-06       Impact factor: 4.584

5.  Moderating the Enthusiasm of Sleeve Gastrectomy: Up to Fifty Percent of Reflux Symptoms After Ten Years in a Consecutive Series of One Hundred Laparoscopic Sleeve Gastrectomies.

Authors:  Yannick Mandeville; Ruth Van Looveren; Peter-Jan Vancoillie; Xander Verbeke; Katrien Vandendriessche; Patrick Vuylsteke; Paul Pattyn; Bart Smet
Journal:  Obes Surg       Date:  2017-07       Impact factor: 4.129

6.  Roux-en-Y reconstruction for failed fundoplication.

Authors:  Konstantinos I Makris; Tommy Lee; Sumeet K Mittal
Journal:  J Gastrointest Surg       Date:  2009-09-02       Impact factor: 3.452

7.  Does BMI predict recurrence or complications after reoperative reflux surgery? Review of a single center's experience and a comparison of outcomes.

Authors:  E Wakeam; J Wee; A Lebenthal; S O Ali; R J Gilbert; R Bueno
Journal:  J Gastrointest Surg       Date:  2014-09-17       Impact factor: 3.452

Review 8.  Surgical Anti-Reflux Options Beyond Fundoplication.

Authors:  Dan Azagury; John Morton
Journal:  Curr Gastroenterol Rep       Date:  2017-07

9.  Surgical management of gastroesophageal reflux disease in obesity.

Authors:  Sayeed Ikramuddin
Journal:  Dig Dis Sci       Date:  2008-07-29       Impact factor: 3.199

10.  Laparoscopic anti-reflux surgery is effective in obese patients with gastro-oesophageal reflux disease.

Authors:  Vivien V Ng; Michael I Booth; Jane J Stratford; Linda Jones; J Sohanpal; Thomas C B Dehn
Journal:  Ann R Coll Surg Engl       Date:  2007-10       Impact factor: 1.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.